10 Affordable Biotech Stocks to Buy Right Now
On July 6, BioPharma Dive reported that drug developers producing new medicines for the treatment of autoimmune disorders and cancer accounted for more than 40% of venture financing...
Posts Tagged ‘NASDAQ:TSHA’
Is Taysha Gene Therapies, Inc. (TSHA) A Good Stock To Buy Now?
Is TSHA a good stock to buy? We came across a bullish thesis on Taysha Gene Therapies, Inc. on BioEquity Watch’s Substack.
Taysha Gene Therapies (TSHA) Reports Financial Results for Q1 2026
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) is one of the best small cap stocks to buy for 10x potential. Taysha Gene Therapies, Inc.
15 Best Small Cap Stocks to Buy for 10x Potential
On May 11, Dan Niles, Niles Investment Management founder, appeared on CNBC’s ‘The Exchange’ to talk about his view on equity markets while conducting a comparison with ...
10 Best US Stocks Under $5 to Buy
On May 8, CNBC reported that Michael Burry has warned that the strong excitement around AI in the stock market is starting to look similar to the final stages of the dot-com bubble...
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q1 2026 Earnings Call Transcript
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q1 2026 Earnings Call Transcript May 6, 2026Taysha Gene Therapies, Inc. misses on earnings expectations.
10 Best Small-Cap Biotech Stocks to Buy According to Hedge Funds
On February 16, Franklin Equity said the biotechnology industry has entered 2026 on a firmer footing following an extended period of market uncertainty in the prior year, noting...
9 Best Healthcare Penny Stocks to Buy According to Hedge Funds
Volatility in the equity market has been on another level in the first quarter of the year.
10 Best Multibagger Penny Stocks to Invest In
Small-cap and penny stocks are often overlooked by Wall Street as they tend to be extremely volatile.
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q4 2025 Earnings Call Transcript
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q4 2025 Earnings Call Transcript March 19, 2026Taysha Gene Therapies, Inc. beats earnings expectations.
Taysha Gene Therapies, Inc. (TSHA) Gains Wells Fargo’s Support on Rett Syndrome Program Progress
TheFly reported on January 5 that Wells Fargo raised its price target on TSHA to $11 from $8 and maintained an Overweight rating.
Here’s What Analysts Are Saying About Taysha Gene Therapies (TSHA)
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) is one of the best strong buy stocks to invest in under $5. Needham maintained a bullish outlook on Taysha Gene Therapies, Inc.
10 Best Strong Buy Stocks to Invest In Under $5
On January 28, JoAnne Feeney, Advisors Capital Management partner and portfolio manager, appeared on CNBC’s ‘Squawk Box’ to talk about the latest market trends. She was...
Taysha Gene Therapies Inc. (TSHA): A Promising Biotech on Rett Syndrome Drug Prospects
Taysha Gene Therapies Inc. (NASDAQ:TSHA) is one of the best penny stocks to buy for 2026.
10 Best Penny Stocks to Buy for 2026
A rally in large-cap growth stocks was the catalyst behind US equities powering to record highs in 2025.
Taysha Gene (TSHA) Hovers Around Its 52-Week High As It Continues to Advance Rett Syndrome Program
With strong 1-year returns and upside potential, Taysha Gene Therapies, Inc.
12 Best Multibagger Stocks to Buy Heading into 2026
As we head into 2026, the biggest question market participants are asking is whether the strong momentum this year can carry over into next year.
Is Taysha Gene Therapies Inc. (TSHA) One of the Must-Buy Penny Stocks to Buy Now?
Taysha Gene Therapies Inc. (NASDAQ:TSHA) is a must-buy penny stock to buy now.
11 Must-Buy Penny Stocks to Buy Now
Markets have continued to rally, with the S&P 500 already up by about 15% for the year.
12 Best American Penny Stocks to Buy Right Now
The S&P 500 is set to outperform the Russell 2000 in annual performance for the 10th time over the past 12 years.
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q3 2025 Earnings Call Transcript
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q3 2025 Earnings Call Transcript November 4, 2025Taysha Gene Therapies, Inc. misses on earnings expectations.
Taysha Gene Therapies Regains Full Global Rights to Lead Rett Syndrome Program TSHA-102
Taysha Gene Therapies Inc. (NASDAQ:TSHA) is one of the best NASDAQ stocks under $5 to buy now.
Raymond James Initiates Strong Buy on Taysha (TSHA) Amid Rett Syndrome Trial Momentum
Taysha Gene Therapies Inc. (NASDAQ:TSHA) is one of billionaire Steve Cohen’s small-cap stock picks with huge upside potential.
11 Best NASDAQ Stocks Under $5 to Buy Now
On October 9, Scott Ladner, Chief Investment Officer at Horizon Investments, appeared on CNBC to suggest that AI remains the key market driver along with tech.
Billionaire Steve Cohen’s 10 Small-Cap Stock Picks with Huge Upside Potential
Known for speed, agility, and a high-risk, high-reward investment approach, Steve Cohen is one of the most successful hedge fund managers on Wall Street.
Taysha Gene Therapies Inc. (TSHA) is ‘Market Perform’ on Rett Syndrome Therapy: JMP Securities
Taysha Gene Therapies Inc. (NASDAQ:TSHA) is one of the best healthcare penny stocks to buy now.
11 Best Healthcare Penny Stocks to Buy Now
The US healthcare sector is one of the biggest in the world, with spending expected to reach $5.3 trillion this year.
Piper Sandler Maintains a Buy on Taysha Gene Therapies (TSHA), Sets a PT of $9
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) is one of the top strong buy stocks under $5 to buy now.
15 Strong Buy Stocks Under $5 to Buy Now
On August 22, Tom Lee, head of research and chief investment officer of Fundstrat Capital, appeared on CNBC’s ‘Squawk on the Street’ to talk about what he thinks about Fed...
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q2 2025 Earnings Call Transcript
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q2 2025 Earnings Call Transcript August 12, 2025Taysha Gene Therapies, Inc. misses on earnings expectations.
Wells Fargo Remains Bullish on Taysha Gene Therapies (TSHA)
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) is one of the best strong buy penny stocks to buy now.
10 Best Strong Buy Penny Stocks to Buy Now
On July 28, Alan Rechtschaffen, UBS Global Wealth senior portfolio manager, appeared on CNBC’s ‘Money Movers’ to talk about the markets, his Fed outlook, and more.
BofA Securities Affirms ‘Buy’ Rating on Taysha Gene Therapies (TSHA) on TSHA-102 Prospects
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) is one of the penny stocks that will skyrocket.
Needham Maintains a Buy on Taysha Gene Therapies (TSHA), Keeps PT at $8
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) is one of the best biotech penny stocks to buy right now.
14 Best Biotech Penny Stocks to Buy Right Now
On July 8, Mizuho’s healthcare strategist Jared Holz appeared on CNBC’s ‘Closing Bell Overtime’ to talk about whether it is time for the biotech sector to undergo a breakout...
10 Penny Stocks That Will Skyrocket
Valuations in the equity markets sit at historical highs, raising questions about future market performance.
Cantor Fitzgerald Reiterates “Overweight” Rating on Taysha (TSHA) for Positive TSHA-102 Clinical Data
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) is one of the 10 best healthcare penny stocks to buy according to analysts.
10 Best Healthcare Penny Stocks to Buy According to Analysts
According to the Centers for Medicare & Medicaid Services (CMS), the US healthcare sector accounted for approximately 17.6% of GDP in 2023.
Jefferies Maintains a Buy on Taysha Gene Therapies (TSHA) With an $8 PT
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) is one of the 13 Best Long-Term Penny Stocks to Buy According to Analysts.
13 Best Long-Term Penny Stocks to Buy According to Analysts
On June 18, Société Générale's Subadra Rajappa appeared on CNBC to talk about her expectations from the Fed.
Taysha Gene Therapies Releases TSHA-102 Clinical Program Updates
Details of Taysha Gene Therapies, Inc.
Needham Lifts Taysha Gene Therapies (TSHA) PT to $8, Cites Positive Clinical Data
On June 2, Needham raised its price target for Taysha Gene Therapies Inc. (NASDAQ:TSHA) to $8 from $6, while maintaining a Buy rating on the stock.
Taysha Gene Therapies (TSHA) Price Target Raised by JMP on Positive Rett Syndrome Trial Data
On May 29, JMP Securities Silvan Tuerkcan revised the firm's view on Taysha Gene Therapies, Inc.
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q1 2025 Earnings Call Transcript
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q1 2025 Earnings Call Transcript May 15, 2025Taysha Gene Therapies, Inc. reports earnings inline with expectations.
10 Best Short Squeeze Stocks to Buy According to Analysts
Stock market trading has an ever-changing environment. Short squeeze is among the few phenomena capable of capturing and holding the attention of such markets.
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q4 2024 Earnings Call Transcript
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q4 2024 Earnings Call Transcript February 26, 2025Taysha Gene Therapies, Inc. beats earnings expectations.
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q3 2024 Earnings Call Transcript
Operator: Greetings. And welcome to the Taysha Gene Therapies’ Third Quarter 2024 Earnings Call. At this time, all participants are in listen-only mode.
10 Most Promising Biotech Stocks According to Hedge Funds
Biotechnology stocks are known for their high risk, making them some of the most volatile in the market.
Hedge Fund Resource Center
